"We are pleased to be able to provide grants to these dedicated medical students," said Richard Harding MD, president of the American Psychiatric Foundation. "Through the generous charitable gift from Otsuka America Pharmaceutical, Inc. and the initiative of these students, communities are improving the quality of mental health services for the underserved."
The Helping Hands Grant Program raises awareness of mental illness and the importance of early recognition and builds an interest amongst medical students in psychiatry and working in underserved communities.
About the American Psychiatric Foundation
The American Psychiatric Foundation is the philanthropic and educational arm of the American Psychiatric Association. The mission of the foundation is to advance understanding that mental illnesses are real and can be effectively treated. For more information, please visit the foundation's Web site at http://www.psychfoundation.org .
About Otsuka America Pharmaceutical, Inc.
Otsuka America Pharmaceutical, Inc. (OAPI) is a successful, innovative,
fast-growing healthcare company that commercializes Otsuka-discovered and
other product opportunities in North America, with a strong focus on and
commitment to neuroscience, cardiovascular and gastrointestinal therapeutic
treatments. OAPI is dedicated to improving patients' health and the quality
of human life. The company is part of the Otsuka Pharmaceutical Group,
which is comprised of 99 companies and approximately 31,000 people in 18
countries and regions around the world. Otsuka and its consolidated
subsidiaries earned US$7.2 billion in annual revenues in fiscal 2006. OAPI
is wholly owned by Otsuka America, Inc. (OAI), which is the holding company
for Otsuka Pharmaceutical Co., Ltd.'s (OPC) interests in the US. OAI is
wholly owned by OPC. For additional information, please visit
| SOURCE Otsuka America Pharmaceutical, Inc. Copyright©2008 PR Newswire. All rights reserved |